This is an old revision of the document!

---

Example Page Group_1_TA_Agata_Kieliszek_Presentation_1_Immune responses against SARS-CoV-2;

Group_2_TA_Nathan_Roberge_Presentation_1_Pathogenesis and transmission of SARS-CoV-2;

Group_3_TA_Agata_Kieliszek_Presentation_1_Therapeutic targeting of SARS-CoV-2;

Group_4_TA_Nathan_Roberge_Presentation_1_Vaccine treatment of SARS-CoV-2;

Group_5_TA_Agata_Kieliszek_Presentation_1_Stem cell models and/or therapies for SARS-CoV-2;

Group_6_TA_Nathan_Roberge_Presentation_1_Diagnostics of SARS-CoV-2;